Duhilag, Trecia Mae T.
HRN: 14-37-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/03/2023
08/09/2023
IVT
500mg
Now Then Q 8 Hrs
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes